Date posted
Jan
13
MichBio invites Michigan’s bio-industry community to join two upcoming federal legislative fly-ins in Washington, DC, offering direct...
Read PostFederal Advocacy
Voices Heard in Washington: Federal Advocacy for Bio Community
Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
Jan
13
In a detailed response to the White House Office of Science and Technology Policy (OSTP), the Biotechnology Innovation Organization (BIO) urged...
Read Post
Date posted
Jan
13
This month, the U.S. Food and Drug Administration (FDA) took a notable step toward modernizing oversight of digital health technologies -...
Read Post
Date posted
Jan
13
The U.S. Department of Health and Human Services (HHS) has formally lent its support to the Give Kids A Chance Act - landmark legislation...
Read Post
Date posted
Dec
22
In late December 2025, Congress completed action on the FY 2026 National Defense Authorization Act (NDAA)and with it, the...
Read Post
Date posted
Dec
22
Access to capital remains one of the most persistent challenges facing early-stage life sciences companies. On December 11, the U.S. House of...
Read Post
Date posted
Dec
22
Mergers and acquisitions (M&A) are a defining feature of the global life sciences industry. While often discussed in terms of market...
Read Post
Date posted
Dec
22
The U.S. Food and Drug Administration (FDA) has taken a noteworthy step toward modernizing how it collaborates with innovative technology...
Read Post
Date posted
Dec
8
On December 1, 2025, Washington and London announced an “agreement in principle” that does two big things at once: it shields...
Read Post
Date posted
Dec
8
The Advanced Research Projects Agency for Health (ARPA-H) – Health & Human Service (HHS)’s “high-risk,...
Read Post
Date posted
Dec
8
After the FDA’s Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) authority lapsed at the end of 2024, patient groups and drug...
Read Post
Date posted
Dec
8
A major bipartisan push to overhaul pharmacy benefit managers (PBMs) is back on the Senate agenda. On Dec. 4, Senate Finance Committee...
Read Post